Found 14 matching trials
Phase 2 Study IV QUZYTTIR™ (Cetirizine Hydrochloride Injection) vs V Diphenhydramine PHASE2 This study is designed to compare the number of infusion reactions to treat...
Show More Location
St.Joseph Heritage Care
Learn More & Join Trial
A Study of Xolair (Omalizumab) in Patients With Chronic Idiopathic Urticaria (CIU) Who Remain Symptomatic With Antihistamine Treatment (H1) PHASE2 The study is a Phase II, dose-ranging, multicenter, randomized, double-blin...
Show More Location
Multiple Locations
Learn More & Join Trial
Rash & Diarrhea Prophylaxis With Capivasertib PHASE2 This is a randomized, multicenter, phase II clinical trial evaluating proph...
Show More Learn More & Join Trial
A Study to Evaluate the Impact on Skin (Injection Site) Reactions of Taking an Antihistamine (Zyrtec®) or Placebo Prior to Daily Injections of Copaxone®. PHASE4 This study is designed to compare injection skin (injection site) reactions...
Show More Location
Multiple Locations
Learn More & Join Trial
Phase III Clinical Study of Cetirizine Hydrochloride Injection in Treatment of Acute Urticaria PHASE3 The objective of this study was to evaluate the efficacy and safety of ceti...
Show More Location
Chinese Academy of Medical Sciences, Peking Union Medical College Hospital
Learn More & Join Trial
A Multi-dose Study of ARC-520 in Patients With Hepatitis B 'e' Antigen (HBeAg) Negative, Chronic Hepatitis B Virus (HBV) Infection PHASE2 Patients with chronic HBV infection will receive either ARC-520 or placebo ...
Show More Learn More & Join Trial
Intralymphatic Immunotherapy for House Dust Mite, Dog, and Cat Allergy Using Tyrosine S® in Allergic Rhinitis PHASE1 The investigators will perform double-blinded placebo-controlled randomized...
Show More Location
Gachon University Gil Medical Center
Learn More & Join Trial
Pilot Phase III Clinical Trial of JDP-205 IV Injection for Treatment of Acute Urticaria PHASE3 This is a multicenter, parallel group, randomized, double-blind pilot Phase...
Show More Location
University of Cincinnati, Department of Emergency Medicine
Learn More & Join Trial
A Study to Characterize Subcutaneous or Intravenous Alemtuzumab in Patients With Progressive Multiple Sclerosis PHASE1 Primary Objective:
* To characterize the pharmacodynamic profile of 2 trea...
Show More Location
Investigational Site Number 724001
Learn More & Join Trial
Clinical Trial Comparing JDP-205 to Diphenhydramine Injection for the Treatment of Acute Urticaria PHASE3 This is a multicenter, parallel group, randomized, double-blind, active con...
Show More Location
Univ of Cincinnati Medical Center
Learn More & Join Trial